AO
Actis Oncology clinical programs
TopicExpert statements
1
What experts have said about Actis Oncology clinical programs
1 statement · 1 neutral
Actis expects initial data from its Nectin4 and B7H3 programs in 2027
“publicly guided to initial clinical data in both of these lead programs in 2027”
Open the episode · All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades LiveListen at 32:38
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.